IOSPress

This publication contains a series of articles by experts in the ovarian cancer field, who present new developments in the identification and understanding of biomarkers for this tumor. Articles include ones on new hypotheses on the molecular development of ovarian cancer, SP markers of risk, biomarkers that are specific for the different histiologic subtypes, and new biomarkers and approaches for the early detection of ovarian cancer. Further, new molecular technologies have allowed for the analysis and characterization of specific cellular components of ovarian tumors identifying biomarkers of tumor associated immune and endothelial cells. Many of these biomarkers may serve not only as markers of clinical and biology interest but also as potential therapeutic and imaging targets which could significantly improve the survival of patients with this disease.